• U.S. Burden of Skin and Subcutaneous Diseases Increasing

    Healthday News Conditions, HealthDay News Physician's Briefing June 25, 2020
  • Can dermatology employers require employees to receive the COVID-19 vaccine?

    American Academy of Dermatology AAD, Conditions, Coronavirus, COVID-19 January 28, 2021
  • THE 2020 VISION FOR NEMOLIZUMAB IN ATOPIC DERMATITIS

    American Academy of Dermatology AAD, Atopic Dermatitis, Conditions, Dermatology January 26, 2021
  • Expression of retinoid receptors in hand eczema.

    ClinOwl Atopic Dermatitis, ClinOwl, Conditions, Eczema October 1, 2020
  • S. aureus Agr Virulence Tied to Atopic Dermatitis in Infants

    Healthday News Atopic Dermatitis, Conditions, Eczema July 28, 2020
  • Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces.

    ClinOwl ClinOwl, Conditions, COVID-19, Psoriasis July 26, 2020

DermConnect® is an official licensee of the American Academy of Dermatology.

DermConnect®
Navigation
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
Home 2021 October

Post Archive by Month

View Post

Seven Best Diagnostic Criteria ID’d for Childhood Psoriasis

In HealthDay News
by Healthday
October 27, 2021

Presence of two or more of these criteria has a sensitivity and specificity of more than 70 percent, the authors say

View Post

Predictors Explored for Response to UVB Phototherapy in Psoriasis

In HealthDay News
by Healthday
October 26, 2021

Higher body mass index and positive smoking status predict poorer phototherapy response

View Post

USPSTF Presents New Approach to Sex, Gender in Recommendations

In HealthDay News, OBGYN & Women's Health
by Healthday
October 25, 2021

Task force will use inclusive approach to identify issues related to sex, gender in guideline development; will use gender-neutral language

View Post

Psoriatic Arthritis May Up Risk for Preterm Birth, C-Section

In HealthDay News, OBGYN & Women's Health
by Healthday
October 20, 2021

Risk for preterm birth increased with antirheumatic treatment for psoriatic arthritis — particularly biologics — during pregnancy

View Post

More Than Half of COVID-19 Survivors Have Postacute Sequelae

In HealthDay News
by Healthday
October 19, 2021

Most common sequelae include functional mobility impairments, pulmonary abnormalities, and mental health disorders

View Post

FDA Approves First Interchangeable Biosimilar for Inflammatory Diseases

In HealthDay News
by Healthday
October 19, 2021

Cyltezo is first interchangeable monoclonal antibody for RA, psoriatic arthritis, ankylosing spondylitis, Crohn disease, ulcerative colitis, chronic plaque psoriasis

View Post

Biologic Therapies Available for Pediatric Patients With Asthma

In HealthDay News
by Healthday
October 18, 2021

Pediatricians should refer patients to a pediatric subspecialist to identify candidates for biologic therapy and select the appropriate medication

View Post

U.S. Spending Up for Cancer Drugs Lacking Evidence of Survival Benefit

In HealthDay News, OBGYN & Women's Health
by Healthday
October 18, 2021

From 2017 to 2019, Medicare spending on 10 accelerated approval drugs with lack of overall survival benefit increased to $569 million

View Post

Inbox Time Linked to Reduced Odds of Physician Turnover

In HealthDay News, OBGYN & Women's Health
by Healthday
October 18, 2021

And increase in mean total messages received per day seen for physicians during March 2020 to June 2021

View Post

Former FDA Chief Robert Califf a Contender to Head Agency Again

In HealthDay News, OBGYN & Women's Health
by Healthday
October 14, 2021

FDA has not had a permanent head for more than eight months, is being overseen by Acting Commissioner Janet Woodcock

  • Page 1 of 3
  • 1
  • 2
  • 3
  • →

TRENDING

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease
  • Lymph Node Dissection Declining in SLN-Positive Melanoma
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

LATEST ARTICLES

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus March 16, 2022
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites March 11, 2022
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease March 11, 2022
  • Lymph Node Dissection Declining in SLN-Positive Melanoma March 9, 2022
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down March 9, 2022

Quick Links

  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

SCHEDULE

October 2021
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
« Sep   Nov »

All content indicated on this website as authored by "AAD" is owned by and licensed with the permission of the American Academy of Dermatology (“AAD”) for personal educational use.

The content may not be distributed in whole or in part to any third parties without express written permission from AAD,
nor may viewers of this site translate, edit, modify or otherwise create derivative works from the content.

The licensing of the content by AAD does not constitute or imply any endorsement of any company and/or any of its goods, services or written work product.

 

  • Home
  • Atopic Dermatitis
  • Psoriasis
  • Skin Cancer